ConductScience.org, home

Paper2016707

2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.

Ueeda M and 3 others. J Med Chem, 1991. Cited by 56 papers, by iCite.

Cite this record

ConductScience Library. 2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor. Papers, record 2016707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2016707

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.
PubMed
Journal
J Med Chem
PubMed
Year
1991
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
2.39
iCite
Revised in PubMed
2019-07-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ueeda MM
2Thompson RDR D
3Arroyo LHL H
4Olsson RAR A

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenosineMajor topic
Coronary VesselsMajor topic
HeartMajor topic
Muscle, Smooth, VascularMajor topic
Receptors, PurinergicMajor topic
Animals
Atrioventricular Node
Guinea Pigs
In Vitro Techniques
Models, Molecular
Molecular Conformation
Molecular Structure
Rats
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HL 30391NHLBI NIH HHSUnited StatesR01HL030391PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
37741687A2A adenosine receptor agonists, antagonists, inverse agonists and partial agonists.Int Rev Neurobiol2023https://conductscience.org/library/papers/37741687PubMed
31907833Comparison of trinitroglycerin and adenosine as provocative agents for head-up tilt test in patients with unexplained syncope: a semi-crossover randomized clinical trial with prospective follow-up.J Interv Card Electrophysiol2021https://conductscience.org/library/papers/31907833PubMed
154766692-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors.Biochem Pharmacol2004https://conductscience.org/library/papers/15476669PubMed
12673185Pharmacologic stress testing: new methods and new agents.J Nucl Cardiol2003https://conductscience.org/library/papers/12673185PubMed
9831724Cellular mechanisms by which adenosine induces vasodilatation in rat skeletal muscle: significance for systemic hypoxia.J Physiol1999https://conductscience.org/library/papers/9831724PubMed
9831723Adenosine receptor subtypes and vasodilatation in rat skeletal muscle during systemic hypoxia: a role for A1 receptors.J Physiol1999https://conductscience.org/library/papers/9831723PubMed
9019545The role of the A(2A) adenosine receptor subtype in functional hyperaemia in the hindlimb of anaesthetized cats.J Physiol1996https://conductscience.org/library/papers/9019545PubMed
8692279Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists.Naunyn Schmiedebergs Arch Pharmacol1996https://conductscience.org/library/papers/8692279PubMed
8321327Covalent binding of a selective agonist irreversibly activates guinea pig coronary artery A2 adenosine receptors.Naunyn Schmiedebergs Arch Pharmacol1993https://conductscience.org/library/papers/8321327PubMed
8097283The cardiovascular effects of selective adenosine A1 and A2 receptor agonists in the pithed rat: no role for glibenclamide-sensitive potassium channels.Naunyn Schmiedebergs Arch Pharmacol1993https://conductscience.org/library/papers/8097283PubMed
7925617Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor.Eur J Pharmacol1994https://conductscience.org/library/papers/7925617PubMed
7582508The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist.Br J Pharmacol1995https://conductscience.org/library/papers/7582508PubMed
1738138Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.J Med Chem1992https://conductscience.org/library/papers/1738138PubMed
1513184Adenosine A1 and A2 receptors: structure--function relationships.Med Res Rev1992https://conductscience.org/library/papers/1513184PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2016707

GET https://conductscience.org/api/papers/v1/2016707/authors